Latest News Archive

Please select Category, Year, and then Month to display items

Vishuis aiming for number seven

12 April 2019 | Story Ruan Bruwer | Photo Varsity Cup

Managing his players is of the utmost importance if the University of the Free State’s (UFS) Abraham Fischer Residence (Vishuis) is to claim a fourth straight and seventh overall national hostel title, says Zane Botha, head coach of the hostel team at the UFS.

The Varsity Hostel competition, which will be taking place in Stellenbosch, has been drastically shortened to only three days of rugby because Steinhoff has withdrawn their sponsorship.

If Vishuis makes it to the final, they will play three matches in four days.
They will face the Kovacs of the University of the Western Cape (UWC) on Friday 12 March 2019, followed by the semi-final on Saturday and the final on Monday. The final will take place at 14:00 and will be broadcast live on SuperSport.

“This will be new territory for us. We will have to make good tactical decisions; it won’t be possible for a prop to play for 70 minutes in all three encounters,” said Botha, who is in his third year with the hostel.

The team played three warm-up matches, which they won convincingly. We still have the core of last year’s team, together with some exciting youngsters.
Botha explained that they kept to their strategy of working harder than anyone else on the practice field and during matches. In last year’s final, Vishuis defeated Patria of the North-West University by 55-29, which was the biggest winning margin in the 11 years of the competition. Vishuis walked away with the crown in 2010, 2012, 2013, 2016, 2017, and 2018.

News Archive

New research informs improved treatment of brain inflammation

2017-10-13

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish

Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept